Hinderer S, Schenke-Layland K. Cardiac fibrosis - A short review of causes and therapeutic strategies. Adv Drug Deliver Rev. 2019;146:77–82.

Article  CAS  Google Scholar 

Adao DMT, Ching C, Fish JE, Simmons CA, Billia F. Endothelial cell-cardiomyocyte cross-talk: understanding bidirectional paracrine signaling in cardiovascular homeostasis and disease. Clin Sci. 2024;138:1395–419.

Article  CAS  Google Scholar 

Kovacic JC, Dimmeler S, Harvey RP, Finkel T, Aikawa E, Krenning G. Endothelial to mesenchymal transition in cardiovascular disease: JACC state-of-the-art review. J Am Heart Assoc. 2019;73:190–209.

Google Scholar 

Wang Z, Stuckey DJ, Murdoch CE, Camelliti P, Lip GYH, Griffin M. Cardiac fibrosis can be attenuated by blocking the activity of transglutaminase 2 using a selective small-molecule inhibitor. Cell Death Dis. 2018;9:613.

Article  PubMed  PubMed Central  Google Scholar 

Zhang GH, Yu FC, Li Y, Wei Q, Song SS, Zhou FP. Prolyl 4-hydroxylase domain protein 3 overexpression improved obstructive sleep apnea-induced cardiac perivascular fibrosis partially by suppressing endothelial-to-mesenchymal transition. J Am Heart Assoc. 2017;6:e006680.

Zeisberg EM, Tarnavski O, Zeisberg M, Dorfman AL, McMullen JR, Gustafsson E, et al. Endothelial-to-mesenchymal transition contributes to cardiac fibrosis. Nat Med. 2007;13:952–61.

Article  CAS  PubMed  Google Scholar 

Tombor LS, John D, Glaser SF, Luxán G, Forte E, Furtado M. Single cell sequencing reveals endothelial plasticity with transient mesenchymal activation after myocardial infarction. Nat Commun. 2021;12:681.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Alemasova EE, Lavrik OI. Poly(ADP-ribosyl)ation by PARP1: reaction mechanism and regulatory proteins. Nucleic Acids Res. 2019;47:3811–27.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jagtap P, Szabó C. Poly(ADP-ribose) polymerase and the therapeutic effects of its inhibitors. Nat Rev Drug Discov. 2005;4:421–40.

Article  CAS  PubMed  Google Scholar 

Li Z, Guo Z, Lan R, Cai S, Lin Z, Li J. The poly(ADP-ribosyl)ation of BRD4 mediated by PARP1 promoted pathological cardiac hypertrophy. Acta Pharmacol Sin B. 2021;11:1286–99.

Article  CAS  Google Scholar 

Lu J, Zhang R, Hong H, Yang Z, Sun D, Sun S, et al. The poly(ADP-ribosyl)ation of FoxO3 mediated by PARP1 participates in isoproterenol-induced cardiac hypertrophy. Biochim Biophys Acta Biomembr. 2016;1863:3027–39.

Article  CAS  Google Scholar 

Wang L, Li Z, Tan Y, Li Q, Yang H, Wang P. PARP1 interacts with STAT3 and retains active phosphorylated-STAT3 in nucleus during pathological myocardial hypertrophy. Mol Cel Endocrinol. 2018;474:137–50.

Article  CAS  Google Scholar 

Li Q, Li ZM, Sun SY, Wang LP, Wang PX, Guo Z. PARP1 interacts with HMGB1 and promotes its nuclear export in pathological myocardial hypertrophy. Acta Pharmacol Sin. 2019;40:589–98.

Article  CAS  PubMed  Google Scholar 

Wang L, Wang P, Xu S, Li Z, Duan DD, Ye J. The cross-talk between PARylation and SUMOylation in C/EBPβ at K134 site participates in pathological cardiac hypertrophy. Int J Biol Sci. 2022;18:783–99.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Fan M, Yang K, Wang X, Chen L, Gill PS, Ha T. Lactate promotes endothelial-to-mesenchymal transition via Snail1 lactylation after myocardial infarction. Sci Adv. 2023;9:eadc9465.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Li J, Zhang Y, Li C, Xie J, Liu Y, Zhu W. HSPA12B attenuates cardiac dysfunction and remodelling after myocardial infarction through an eNOS-dependent mechanism. Cardiovas Res. 2013;99:674–84.

Article  CAS  Google Scholar 

He Y, Li S, Jiang L, Wu K, Chen S, Su L. Palmitic acid accelerates endothelial cell injury and cardiovascular dysfunction via palmitoylation of PKM2. Adv Sci. 2025;12:e2412895.

Article  Google Scholar 

Kuno A, Hosoda R, Tsukamoto M, Sato T, Sakuragi H, Ajima N. SIRT1 in the cardiomyocyte counteracts doxorubicin-induced cardiotoxicity via regulating histone H2AX. Cardiovasc Res. 2023;118:3360–73.

Article  PubMed  Google Scholar 

Wang J, Niu N, Xu S, Jin ZG. A simple protocol for isolating mouse lung endothelial cells. Sci Rep-UK. 2019;9:1458.

Article  Google Scholar 

Xiong J, Kawagishi H, Yan Y, Liu J, Wells QS, Edmunds LR. A metabolic basis for endothelial-to-mesenchymal transition. Mol Cell. 2018;69:689–98.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Vilar E, Bartnik CM, Stenzel SL, Raskin L, Ahn J, Moreno V. MRE11 deficiency increases sensitivity to poly(ADP-ribose) polymerase inhibition in microsatellite unstable colorectal cancers. Cancer Res. 2011;71:2632–42.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tai S, Sun J, Zhou Y, Zhu Z, He Y, Chen M. Metformin suppresses vascular smooth muscle cell senescence by promoting autophagic flux. J Adv Res. 2022;41:205–18.

Article  CAS  PubMed  Google Scholar 

Mao J, Wang D, Wang D, Wu Q, Shang Q, Gao C. SIRT5-related desuccinylation modification of AIFM1 protects against compression-induced intervertebral disc degeneration by regulating mitochondrial homeostasis. Exp Mol Med. 2023;55:253–68.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Liu T, Zhou L, Yang K, Iwasawa K, Kadekaro AL, Takebe T. The β-catenin/YAP signaling axis is a key regulator of melanoma-associated fibroblasts. Signal Transduct Target Ther. 2019;4:63.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhai KF, Zheng JR, Tang YM, Li F, Lv YN, Zhang YY. The saponin D39 blocks dissociation of non-muscular myosin heavy chain IIA from TNF receptor 2, suppressing tissue factor expression and venous thrombosis. Br J Pharmacol. 2017;174:2818–31.

Wu J, Gou W, Wang Z, Chang H, Li D, Hou W. Discovery of the radio-protecting effect of Ecliptae Herba, its constituents and targeting p53-mediated apoptosis in vitro and in vivo. Acta Pharmacol Sin B. 2023;13:1216–30.

Article  CAS  Google Scholar 

Amrute JM, Luo X, Penna V, Yang S, Yamawaki T, Hayat S. Targeting immune-fibroblast cell communication in heart failure. Nature. 2024;635:423–33.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Maciejak A, Kiliszek M, Michalak M, Tulacz D, Opolski G, Matlak K. Gene expression profiling reveals potential prognostic biomarkers associated with the progression of heart failure. Genome Med. 2015;7:26.

Article  PubMed  PubMed Central  Google Scholar 

Koenig AL, Shchukina I, Amrute J, Andhey PS, Zaitsev K, Lai L. Single-cell transcriptomics reveals cell-type-specific diversification in human heart failure. Nat Cardiovasc Res. 2022;1:263–80.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Qaqorh T, Takahashi Y, Sameshima K, Otani K, Yazawa I, Nishida Y. Atf3 controls transitioning in female mitochondrial cardiomyopathy as identified by spatial and single-cell transcriptomics. Sci Adv. 2025;11:eadq1575.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chiu SP, Camacho CV, Kraus WL. Development and characterization of recombinant ADP-ribose binding reagents that allow simultaneous detection of mono and poly ADP-ribose. J Biol Chem. 2024;300:107609.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gao A, Su Z, Shang Z, He C, Miao D, Li X. TAB182 aggravates progression of esophageal squamous cell carcinoma by enhancing β-catenin nuclear translocation through FHL2 dependent manner. Cell Death Dis. 2022;13:900.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Shi M, Cui H, Shi J, Mei Y. Silencing FHL2 inhibits bleomycin-induced pulmonary fibrosis through the TGF-β1/Smad signaling pathway. Exp Cell Res. 2023;423:113470.

Article